Research

shyarkinchocolateandflu.png

New Drug Combo Outperforms Tamiflu in Fighting Flu

7 August, 2025

A surprising new drug combo—including a compound found in chocolate—has outperformed Tamiflu in fighting the flu, according to a study published in PNAS. The mix of Theobromine and Arainosine proved far more effective against a range of flu strains, including drug-resistant versions of bird and swine flu. By targeting a key viral weakness, this breakthrough could lead to stronger, longer-lasting treatments—not just for the flu, but potentially for other viruses as well.

Staff
Research
Medicine
bettyschwartzandlarvae.png

Waste Not: How Insect Oil Could Revolutionize Animal Wellness

7 August, 2025

A new study reveals that oil extracted from black soldier fly larvae (BSFL) has potent anti-inflammatory effects on immune cells. The research found that a modified version of the oil can suppress harmful inflammatory signals while supporting metabolic health. The findings offer exciting potential for sustainable, natural feed additives that support animal immunity and reduce reliance on synthetic drugs.

Staff
Research
80-Year-OldFungi

From Herbarium to Life: Reviving 80-Year-Old Fungi Offers New Clues for Sustainable Agriculture

31 July, 2025

Researchers have revived 80-year-old fungal pathogens from a museum collection and found that these pre-Green Revolution strains differ significantly from modern ones, revealing how decades of pesticide use and intensive farming have reshaped plant pathogens. By comparing the old and new fungi, the team uncovered critical insights into the evolution of fungicide resistance, environmental adaptation, and plant disease dynamics, paving the way for more sustainable, informed strategies in modern agriculture.

Staff
In the media
Research
michaelbergercancercells

Powering Up T Cells: A New Path in Cancer Immunotherapy

31 July, 2025

Researchers have discovered a way to make the immune system’s T cells significantly more effective at fighting cancer. By blocking a protein called Ant2, they were able to reprogram how these cells consume and generate energy—essentially rewiring their internal power supply. This shift makes T cells more active, resilient, and better at attacking tumors. The findings open the door to new treatments that could strengthen the body’s own immune response, offering a smarter, more targeted approach to cancer therapy.

Staff
In the media
Research
Medicine
tomatoesin3d

Tomatoes in 3D: Breakthrough in Plant Monitoring

31 July, 2025

A team from the Hebrew University of Jerusalem has developed a low-cost, non-invasive method to estimate total leaf area in dwarf tomato plants using 3D reconstruction from standard video footage. The study applies structure-from-motion techniques and machine learning to predict plant growth with remarkable accuracy. This innovative approach eliminates the need for expensive sensors or destructive sampling, making precision agriculture more accessible. The method holds promise for scaling crop monitoring across greenhouses and open fields alike.

Staff
Research
2025asperprizecompetition

Airovation Technologies Awarded Top Honor in 2025 Hebrew University Asper Prize Competition

27 July, 2025

Airovation Technologies was awarded the prestigious 2025 Asper Prize for “The Hebrew University Rising Startup”. The prize, part of a competition launched by ASPER-HUJI Innovate, the university’s Center for Innovation and Entrepreneurship in collaboration with the Asper Foundation, drew entries from more than fifty startups. Airovation Technologies secured the top spot after presenting to an international panel of judges.

Staff
In the media
Research
Sciences
TinyBrainCircuit

This Tiny Brain Network Could Hold the Key to Beating Cocaine Addiction

27 July, 2025

Why do so many people relapse after quitting cocaine? A new study from The Hebrew University reveals that a specific “anti-reward” brain circuit becomes hyperactive during withdrawal—driving discomfort and pushing users back toward the drug. Surprisingly, this circuit may also serve as a built-in protective mechanism, offering new hope for addiction treatment.

Staff
Research
Medicine
moleculardegradersofferhopeforbreastcancer

Targeting the “Undruggable”: New Molecular Degraders Offer Hope for Aggressive Breast Cancer

27 July, 2025

In a major stride toward tackling aggressive breast cancer, researchers from The Hebrew University of Jerusalem have developed druglike molecules that degrade a previously “undruggable” cancer-driving protein. The target, HuR—an RNA-binding protein known for stabilizing oncogenic messages—has long eluded traditional therapies. Now, using next-generation strategies involving molecular glues and PROTACs, researchers have uncovered a promising route to disarm HuR and suppress tumor growth from the inside out.

Staff
In the media
Research
Medicine
Prenatal Stress

Female Children May Face Greater Emotional and Immune Challenges from Prenatal Stress, Study Finds

22 May, 2025

A new study has uncovered how stress experienced by mothers during pregnancy leaves a molecular imprint on their babies—starting before birth. The research shows that prenatal stress alters the expression of tiny RNA molecules in newborn blood, particularly in female children, and affects key enzymes in the brain's stress-regulation system. These changes may help explain why some children are more vulnerable to developmental or psychiatric challenges. The study opens new possibilities for early diagnosis and interventions targeting stress-related health risks.

Staff
Research
Medicine